Anti‐cardiolipin IgG autoantibodies are an independent risk factor of COVID‐19 severity

A growing body of evidence indicates that patients with cardiovascular complications are at a higher risk for developing severe Coronavirus Disease 2019 (COVID‐19) (1). In addition, the high incidence of thromboembolic events suggests an important role of COVID‐19‐induced coagulopathy (2). Antiphosp...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis & Rheumatology 2020-06
Main Authors: Bertin, Daniel, Brodovitch, Alexandre, Abdou Beziane, Hug, Sylvia, Bouamri, Afaf, Mege, Jean Louis, Bardin, Nathalie
Format: Article
Language:English
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A growing body of evidence indicates that patients with cardiovascular complications are at a higher risk for developing severe Coronavirus Disease 2019 (COVID‐19) (1). In addition, the high incidence of thromboembolic events suggests an important role of COVID‐19‐induced coagulopathy (2). Antiphospholipid autoantibodies (aPL), that are essential markers for antiphospholipid syndrome, are considered as a cardiovascular risk factor.
DOI:10.1002/art.41409